Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
|Articles|March 2, 2018
- Pharmaceutical Technology-03-02-2018
- Volume 42
- Issue 3
Twin Screw Extruder System
The ZSE 50 MAXX twin screw extruder system from Leistritz Extrusion is suited for a range of compounding tasks.
The ZSE 50 MAXX twin screw extruder system from Leistritz Extrusion is suited for a range of compounding tasks. The system includes a modular design for barrels and screws and an insulated barrels cover. The set also has an extended length that facilitates multiple downstream operations, including multi-stage venting, liquid injection, and up to two of the company’s LSB 50 XX side stuffers for filler/fiber introduction into the melt stream. According to the company, the system can be equipped with a 600-horsepower alternating current motor and produce 1000 kgs+/hr at 1200 screws rpms.
Articles in this issue
over 8 years ago
AR/VR Simulator for Plant Personnel Trainingover 8 years ago
Five-Hundred-Gallon Multi-Shaft Mixerover 8 years ago
Tackling Medicine Shortages in Europeover 8 years ago
A New Method for Risk Assessment of Pharmaceutical Excipientsover 8 years ago
FDA Heightens Drive for Transparencyover 8 years ago
Current Challenges in Bioprocesses Developmentover 8 years ago
Dissolved Oxygen Sensorover 8 years ago
Computerized Systems Validationover 8 years ago
Improving Operations in the LabRelated to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
4
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
5